Human Anti-VEGF Recombinant Antibody (TAB-298CQ)

CAT#: TAB-298CQ

This product is a recombinant human antibody that recognizes VEGF (Vascular endothelial growth factor). The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.

Tested Data
Figure 1 Anti-Human VEGF Recombinant Antibody (TAB-298CQ) in ELISA

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG
  • Specificity
  • Human VEGF (Vascular endothelial growth factor)
  • Species Reactivity
  • Human, Mouse
  • Applications
  • ELISA, Inhib
  • Related Disease
  • Breast cancer, lung cancer

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • VEGF; Vascular endothelial growth factor; VPF; VEGFA
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-298CQ. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Great for Angiogenesis Studies
The Human Anti-VEGF Recombinant Antibody has been excellent in my angiogenesis studies. Its high specificity and sensitivity have allowed me to precisely measure VEGF levels in various cancer models. The availability of this antibody in conjugated forms has been incredibly useful for my extensive ELISA and inhibition experiments.
Breast cancer biomarkers at key points during disease progression
Specifically Addresses Research Needs
From ordering to execution, using this antibody has been seamless. Its design addresses the core needs of research focused on signal transduction involved in angiogenesis. High effectiveness in ELISA applications has pushed my research forward significantly. Creative Biolabs' proactive customer support enhances the entire user experience.

Q&As

  1. What are the potential research applications of the Human Anti-VEGF Recombinant Antibody?

    A: The Human Anti-VEGF Recombinant Antibody is primarily used for research applications in ELISA and inhibition assays. It is crucial for studying the roles of vascular endothelial growth factor (VEGF) in angiogenesis processes, which are integral for cancer research, specifically in cancer signaling pathways and tumor growth studies.

  2. Can this antibody be utilized for detecting VEGF in non-human samples?

    A: Yes, this recombinant antibody is designed for cross-reactivity with both human and mouse VEGF, making it suitable for studies involving animal models. Its specificity also supports its use in diverse biological research to explore comparative biology aspects of different species.

View the frequently asked questions answered by Creative Biolabs Support.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-298CQ, RRID: AB_3111904)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Publications

Peer-reviewed Publications

Our products have been used extensively by scientists all over the world to accelerate their life science research. Here, we present a collection of publications that cite this product.

Schiffmann, Lars Mortimer, et al. "Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer." British journal of cancer 120.1 (2019): 69.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "VEGF"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
Gly-096LC Recombinant Anti-Human VEGF Antibody (Fc glycosylation) ELISA Humanized antibody
Gly-143LC Recombinant Anti-Human VEGF Antibody (Fc glycosylation) ELISA Humanized antibody
CAT Product Name Application Type
Gly-179LC Recombinant Anti-Human VEGF Antibody (Non-glycosylated) ELISA Human antibody
CAT Product Name Application Type
MOR-4485 Rabbit Anti-VEGF Recombinant Antibody (clone SI581DS) ELISA Rabbit IgG
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare